ArticleFrontiers in immunology2026
The immune dysregulation landscape and dynamic regulation of competing endogenous RNAs in spinal cord injury.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Spinal cord injury (SCI) triggers a complex secondary injury cascade that critically limits neural repair. Although microRNAs have been implicated in post-SCI inflammation and neural regeneration, the key competing endogenous RNA (ceRNA) network regulating immune dysregulation remains unclear. Methods: Peripheral blood miRNA data from six SCI patients and six healthy controls were combined with peripheral blood mRNA expression profiles from the GEO dataset (GSE151371) to identify differentially expressed miRNAs and mRNAs. Characteristic miRNAs were screened using LASSO and SVM-RFE machine learning algorithms, with core miRNAs subsequently validated via receiver operating characteristic (ROC) analysis. Their target mRNAs were predicted and validated, enabling the construction of a ceRNA regulatory network. Concurrent immune infiltration analysis was performed. WGCNA was applied to the core mRNAs to define immune-related co-expression modules and conduct functional enrichment. Furthermore, SCI samples were classified into two molecular subtypes with distinct immune microenvironments. Finally, RT-qPCR was used to quantify the expression of core miRNAs in validation cohorts, and functional experiments (CCK-8 and Transwell assays) were performed in C8-D1A astrocytes to assess the roles of selected miRNAs in cell proliferation and migration. Results: Six differentially expressed miRNAs were identified in SCI patients: four upregulated (hsa-miR-3680-5p, hsa-miR-410-3p, hsa-miR-6883-3p, hsa-miR-4508) and two downregulated (hsa-miR-3685, hsa-miR-6798-3p). ROC analysis verified the robust diagnostic value of these core miRNAs, with AUC > 0.85. RT-qPCR validation confirmed these expression patterns in the blood of SCI patients, consistent with bioinformatics predictions, p < 0.05. Their common targets (KLHL3, PRKCH, BACH2, MAP2K6, SIPA1L2) showed opposite expression patterns. WGCNA revealed immune-related modules enriched in T/B cell receptor and MAPK signaling pathways. Immune infiltration analysis indicated increased neutrophils and monocytes, with decreased lymphocytes. Notably, functional assays demonstrated that miR-3680-5p, miR-6798-3p, and miR-6883-3p did not directly affect astrocyte proliferation but significantly modulated astrocyte migration when co-cultured with macrophages, suggesting their involvement in astrocyte-macrophage crosstalk during SCI repair. Conclusion: We constructed an immune-related ceRNA network in SCI, identifying six core miRNAs that regulate immune pathways and astrocyte-macrophage interactions. These findings provide new insights into SCI pathogenesis and potential therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.